Dr. Mark Sircus, one of the most prolific writers in medicine, holds the honorary title of doctor of Oriental medicine and was one of the first nationally certified acupuncturists in the United States. He was trained in acupuncture and oriental medicine at the Institute of Traditional Medicine in Santa Fe, N.M., and in the School of Traditional Medicine of New England in Boston. He served at the Central Public Hospital of Pochutla, in Mexico.
For many years he has been researching into the human condition and into the causes of disease. His primary focus in recent years has been the study of environmental toxicity and iatrogenic diseases. He has written extensively on the poisons in the environment, in our foods, medicines and dental practices. Dr. Sircus is the director of the International Medical Veritas Association (IMVA), which is advocating radical changes in orthodox medicine.
His research and writings bring forth information that others wish to be hidden and he is without doubt “a flame of wonderful insight” and many are thankful for his wisdom and courage. Some people think him a genius in his own right and “his methods of attacking chronic disease beautiful and to the point.”
In a recent post on his blog, Dr Sircus said:
Cannabinoids in Cancer Treatment
THC has been approved by the Food and Drug Administration because medical science confirms its use in a broad variety of clinical situations. Specifically a THC-containing drug called Marinol is FDA approved though it does not come close to effectiveness of natural cannabinoids. Synthetic copies of natural substances rarely if ever maintain the same pharmacological effects as the original and we know this to be especially true in the case of marijuana and the chemicals the pharmaceutical companies manufacture to simulate natural cannabinoids.
Marijuana is a very special natural medicine that increases our chances of beating cancer, though contemporary oncologists are mostly interested in it for its ability to mitigate the nasty side effects of chemo and radiation therapy. They would never think of it as an important part of the actual treatment of cancer.
Marijuana, whose botanical name is cannabis, has been used by humans for thousands of years. It was classified as an illegal drug by many countries in the 20th century. But over the past two decades, there has been a growing movement to legalize it, primarily for medical purposes. Medical marijuana use has surged in the 15 states, including the District of Columbia, that allow its use.
The endocannabinoid system is a set of nerve receptors and related body chemicals that deal with appetite, pain-sensation, mood and memory. The interesting thing about the nerve receptors is that they respond to cannabinoids, one of the components of marijuana. There are many pain-relieving medications available today. Without doubt pain medications are a blessing for the temporary relief of pain as well as for the people who are dying and suffering. The safest pain relievers though are the cannabinoids, which can be used for longer periods of time with fewer side effects and dangers.
I have written several books on cancer and have been championing medical marijuana in my protocols for over five years. I am now writing a book on cannabinoid medicine and even I am surprised with the depth of research that resurrects the popular marijuana medicine from the 1800s and early 1900s.
Medical marijuana is now a cutting-edge medicine—one that has been around the block in the world of medicine and was especially popular in pharmacies until it was made illegal starting in 1913 just after the Federal Reserve Act was passed. The same interests that took control of the money supply took control of the pharmaceutical industry. These fast growing companies needed to make inexpensive drugs and pain medications illegal so they could legally get away with murder from the use of more dangerous synthetic drugs.
All research leads us to the undeniable conclusion that marijuana is the premier cancer medicine mankind has been looking for and finally has found. The problem is that there are special interests whose main interest is that real cures for cancer are never discovered. Actually it’s a mistake to think in terms of cure; it’s better to think in terms of effective treatment, for cancer is a very complicated phenomena with multiple and often concurrent causes. Treatments need to touch down on many if not all the causes to affect a permanent cure.
Everyone who knows of my work knows that I have never recommended single-shot cancer cures. In my bookSodium Bicarbonate – Rich Man’s Poor Man’s Cancer Treatment I made it very clear that I never recommend bicarbonate without magnesium salts or without iodine and several other important anticancer agents.
Oncologists also use sodium bicarbonate when they
administer chemotherapy to buffer the poisonous
nature of the chemo agents as they are administered.
Until this writing, magnesium chloride remained as the number-one priority in my cancer protocol with bicarbonate coming in second, even though bicarbonate offers more immediate benefit in terms of anti-tumor effects. Medical marijuana has been included with my core recommendations but I am now thrusting it to the forefront.
Despite the legal problems, it is time for the field of medicine to wake up to the true value of marijuana in the treatment of disease. Marijuana has moved into a first-place tie with magnesium chloride in my cancer protocol and I am now recommending that it be used universally. Its effect is just too good and its price too low. Some see goodness and affordability as unimportant but anyone with a humane heart must surely recognize the importance of accepting marijuana as a beneficial therapy. Doctors beware; in an age of financial and economic collapse we will be desperate for inexpensive medicines that are safe and universally available.
Read more @ imva.info
Interesting… so why has the US Drug Enforcement Administration recently ruled that Marijuana has no medical use, despite conflicting information from the Institute of Medicine (IOM) and the thousands of people using it to treat conditions that other medicines can’t help with?
U.S. Rules That Marijuana Has No Medical Use. What Does Science Say?
The U.S. Drug Enforcement Administration (DEA) ruled on Friday that marijuana has “no accepted medical use” and should therefore remain illegal under federal law — regardless of conflicting state legislation allowing medical marijuana and despite hundreds of studies and centuries of medical practice attesting to the drug’s benefits.
The judgment came in response to a 2002 petition by supporters of medical marijuana, which called on the government to reclassify cannabis, which is currently a Schedule I drug — like heroin, illegal for all uses — and to place it in Schedule III, IV or V, which would allow for common medical uses.
The DEA ruled that marijuana has “no currently accepted medical use in treatment in the United States,” has a “high potential for abuse,” and “lacks an acceptable level of safety for use even under medical supervision.”
Not only does this decision conflict with state laws, however, it also conflicts with a 1999 report by the Institute of Medicine (IOM), the branch of the National Academy of Sciences charged with answering complex medical questions for Congress. Way back in 1999, the IOM said:
Scientific data indicate the potential therapeutic value of cannabinoid drugs, primarily THC, for pain relief, control of nausea and vomiting, and appetite stimulation; smoked marijuana, however, is a crude THC delivery system that also delivers harmful substances.
In addition, in 2006 the U.S. Food and Drug Administration issued an investigational new drug application, or IND — which grants permission to study a drug with the goal of approving it for marketing if it is safe and effective — for Sativex, an inhalable marijuana-derived drug, which includes both THC and CBD, the main active components of cannabis. So, while one federal agency says the drug is too risky for use even under medical supervision, another is studying it for possible approval for marketing.
The synthetic marijuana-based drugs nabilone and dronabinol (both used to treat nausea and vomiting) are already approved in the U.S. and have been placed in Schedules II and III, respectively. Schedule II includes drugs with high abuse potential like Oxycontin, while Schedule III includes milder painkillers like codeine combined with Tylenol.
Since the IOM report was released more than a decade ago, the evidence for the medical benefits of marijuana and related drugs has continued to increase. In the last three years alone, cannabinoids have been found to help kill breast cancer cells, fight liver cancer, reduce inflammation, have antipsychotic effects and even potentially help stave off the development of Alzheimer’s disease and reduce progression of Huntington’s disease.
Further, a 2011 review of the effectiveness of cannabinoids for non-cancer pain found “no significant adverse effects” and “significant” analgesic effects.
Although the DEA judgment sounds like a setback for medical marijuana advocates, in one important sense it is an advance. The government had long delayed making a judgment on the petition, but now that it has, it makes it possible for advocates to appeal it in federal court. Now, that process can be set in motion.
Source: TIME Healthland